Pain Therapeutics reported $-21345000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US USD 1.77B 602M
Acelrx Pharmaceuticals ACRX:US USD -6632000 6.94M
Amgen AMGN:US USD 2.74B 562M
Biogen BIIB:US USD 1.32B 1.37B
Cara Therapeutics CARA:US USD -23845000 19.37M
Eisai 4523:JP JPY -2181000000 9.62B
Eli Lilly And LLY:US USD 1.68B 466.4M
Geron GERN:US USD -39948000 11.97M
Johnson & Johnson JNJ:US USD 5.82B 18M
Merk MRK:US USD 3.99B 939M
Novartis NOVN:VX USD 2.17B 60M
Novavax NVAX:US USD -127189000 355.77M
Pain Therapeutics PTIE:US USD -21345000 1.43M
Pfizer PFE:US USD 9.41B 2.69B
Roche Holding ROG:VX 11.55B 3.47B